Nomura Holdings’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Nomura Holdings’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-22,130	Closed	-$204K	–	2248
2015 Q4	$204K	Buy	+22,130	New	+$185K	﹤0.01%	1573
2015 Q3	–	Sell	-19,483	Closed	-$183K	–	2133
2015 Q2	$183K	Buy	+19,483	New	+$177K	﹤0.01%	1608
2014 Q2	–	Sell	-34,218	Closed	-$155K	–	3189
2014 Q1	$155K	Sell	34,218 -12,525	-27%	-$60.5K	﹤0.01%	2408
2013 Q4	$236K	Buy	+46,743	New	+$225K	﹤0.01%	1667
2013 Q3	–	Sell	-32,225	Closed	-$159K	–	2748
2013 Q2	$159K	Buy	+32,225	New	+$153K	﹤0.01%	1916

Other funds holding SCLN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's SCLN Position: Q1 2016 in Review

Nomura Holdings sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2016, closing a stake of 22,130 shares — an estimated $204K sold.

Nomura Holdings first reported a position in SCLN in Q2 2013 and held it in 5 quarters. The position peaked at $236K in Q4 2013. 142 funds tracked by Wall St. Rank hold SCLN as of Q1 2016.

Nomura Holdings reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
Nomura Holdings sold 22,130 Sciclone Pharmaceuticals Inc shares in Q1 2016, an estimated $204K.
Nomura Holdings first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
Nomura Holdings's Sciclone Pharmaceuticals Inc position peaked at $236K in Q4 2013.
142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2016.

Based on Nomura Holdings's 13F filing for Q1 2016, filed 16 May 2016.